Apeiron and Rentschler Announces Partnership Agreement

Product News   Aug 02, 2013

 
Apeiron and Rentschler Announces Partnership Agreement
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Horizon Discovery Enters into License Agreement with US Immuno-Oncology Company

Product News

Horizon retains commercial rights over improvements to its technology platforms to develop new cell line technologies and gene delivery IP that can be licensed to customers for applications in biomanufacturing, diagnostic reference standards, and cell therapy.

READ MORE

QIAGEN’s QuantiFERON-TB Gold Plus Gains Approval in Japan

Product News

QIAGEN N.V. announced that Japan’s Ministry of Health Labor and Welfare has approved QuantiFERON®-TB Gold Plus (QFT®-Plus) as an in vitro diagnostic to detect tuberculosis (TB) infection.

READ MORE

Thermo Fisher Scientific Receives Manufacturing Leaders’ Innovation Award

Product News

Advanced analytics and remote diagnostics wireless cold storage monitoring solution voted most innovative product of 2017.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE